clinical trial · NCT01052779
A Trial Comparing Ferumoxytol to Iron Sucrose for the Treatment of Iron Deficiency Anemia in Adult Subjects With Chronic Kidney Disease
AMAG Pharmaceuticals, Inc.·phase2·completed·n = 162
Iron DeficiencyAnemiaKidney DiseaseFerumoxytolIron Sucrose
brief summary
The purpose of the study is to evaluate the safety and efficacy of intravenous (IV) ferumoxytol compared to IV iron sucrose for the treatment of iron deficiency anemia (IDA) in participants with chronic kidney disease (CKD).
started
Mar 1, 2010
primary completion
Jul 19, 2011
completion
Apr 19, 2012
last updated
Jul 25, 2023
official title
Ferumoxytol Compared to Iron Sucrose Trial (FIRST): A Randomized, Multicenter, Trial of Ferumoxytol Compared to Iron Sucrose for the Treatment of Iron Deficiency Anemia in Adult Subjects With Chronic Kidney Disease
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol